Coronavirus LIVE: Applying for emergency vaccine use soon, says Serum CEO

PM Modi interacts at Serum Instiute on Covid vaccine development| Photo: @narendramodi
Coronavirus update: On Friday, India reported 41,353 fresh Covid-19 cases, taking its tally to 9,351,224. The country's death toll mounted to 136,238. At 1,808,550, Maharashtra has the highest number of coronavirus cases, followed by Karnataka 881,086, Andhra Pradesh 866,000, Tamil Nadu 777,616 and Kerala 587,578. Delhi recorded 5,482 fresh Covid-19 cases in a day, while 98 more fatalities linked to the disease pushed the city's death toll to 8,909.

 
Prime Minister Narendra Modi visited Zydus Biotech Park today to review coronavirus vaccine development work at facilities there. From there, PM Modi reached Hyderabad as part of his three-city tour to take stock of Covid-19 vaccine development. he lauded the scientists of Bharat Biotech for their vaccine progress with ICMR. 

World coronavirus update: The global tally of coronavirus cases stands at 61,958,809. While 42,772,849 have recovered, 1,448,231 have died so far. The US, the worst-hit country, has 13,450,712 cases, and 271,025 have died from the disease there. It is followed by India, which has 9,351,224 cases, Brazil (6,238,350), Russia (2,215,533), France (2,196,119).

Stay tuned for the latest coronavirus-related live news.

9:00 PM IST Mumbai reports 1,063 new #COVID19 cases, 880 recoveries/discharges and 17 deaths today. Total cases rise to 2,81,874 including 2,55,345 recoveries/discharges and 10,773 deaths. Active cases stand at 12,753 pic.twitter.com/kbG5rCOpfk — ANI (@ANI) &7

8:34 PM IST Karnataka reports 1,522 new COVID-19 cases, 2,133 recoveries, and 12 deaths, according to the State Health Department Total cases: 8,82,608 Total recoveries: 8,46,082 Total deaths: 11,750 Active cases: 24,757 pic.twitter.com/Fr1dHOdXEX — ANI (@ANI) &7

8:31 PM IST Puducherry reports 46 new #COVID19 cases, 41 discharges. Total positive cases in the Union Territory rise to 36,902 till date, including 519 active cases, 35,774 recoveries & 609 deaths: Directorate of Health & Family Welfare, Government of Puducherry pic.twitter.com/VYSWUh4nQM — ANI (@ANI) &7

8:28 PM IST Maharashtra reports 5,965 new COVID-19 cases,3,937 recoveries, and 75 deaths today, as per the State Health Department Total cases: 18,14,515 Total recoveries: 16,76,564 Active cases: 89,905 Death toll: 46,986 pic.twitter.com/oyXIsp8b02 — ANI (@ANI) &7

7:54 PM IST Serum Institute CEO Adar Poonawalla said that they are process of applying for emergency use authorization of Covishield in the next two weeks. PM is extremely knowledgable now on vaccines & vaccine production. We were amazed at what he already knew. He futher said that there was very little to explain to him, except for going into detail on different variable vaccines & the challenges that they may face ahead. As of now, we don't have anything in writing with the govt of India on how many doses they will purchase but the indication is that it would be 300-400 million doses by July, 2021. "We have built the largest pandemic level facility in Pune & our new campus in Mandri. That was also showcased to the PM with a tour around the facility & a lot of detailed discussions. Vaccine will be distributed initially in India, then we will look at the COVAX countries which are mainly in Africa. The UK & European markets are being taken care of by AstraZeneca & Oxford. Our priority is India & COVAX countries", said Poonawalla to ANI. Adar Poonawalla, CEO, Serum Institute

7:45 PM IST The Indian Council for Medical Research (ICMR) has approved a simple and fast method for COVID-19 testing which can not only increase the number of RT-PCR tests but can also bring down costs, the Council for Scientific and Industrial Research (CSIR) said on Saturday. The method -- Dry Swab-Direct RT-PCR -- developed by CSIR's Centre for Cellular and Molecular Biology, Hyderabad, is a variation of the existing gold standard RT-PCR method and can easily scale up the testing by 2 to 3 fold with no new investment of resources. "After evaluating this method and finding an overall concordance of 96.9 per cent, ICMR has now issued an advisory for the use of CSIR-CCMB dry swab method, considering its lesser cost and quick turn-around time," the CSIR said. The CCMB has been testing samples for coronavirus since April. Having worked closely with healthcare workers of Telangana, it identified some of the key issues that slow the testing process. In response to it, the researchers developed the Dry Swab RNA-extraction free testing method for COVID-19. The Dry Swab-Direct RT-PCR method involves collecting and transporting the nasal swab in dry state, as opposed to using the viral transport medium VTM, which makes the transportation and handling of the samples easy and less prone to spillage and spread of infection. Secondly, the step of RNA isolation from the sample is omitted and involves only simple processing of the sample followed by direct RT-PCR using the kit recommended by the ICMR.

7:21 PM IST Delhi reports 4,998 new COVID-19 cases (out of 69,051 tests), 6,512 recoveries, and 89 deaths, as per Delhi Health Department Total cases: 5,61,742 Total recoveries: 5,16,166 Death toll: 8,998 Active cases: 36,578 pic.twitter.com/HqXOxvlAAe — ANI (@ANI) &7

7:17 PM IST Chandigarh reports 89 new #COVID19 cases taking the total number of cases to 17246. Number of active cases now at 1115 and death toll stands at 274: Health Department, Chandigarh pic.twitter.com/yu8EugPeNJ — ANI (@ANI) &7

6:51 PM IST Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility. pic.twitter.com/PvL22uq0nl — Narendra Modi (@narendramodi) &7

6:30 PM IST Tamil Nadu reported 1,430 new #COVID19 cases, 1,453 discharges, and 13 deaths in the last 24 hours: State Health Department, Govt of Tamil Nadu Total cases: 7,79,046 Total discharges: 7,56,279 Death toll: 11,694 Active cases: 11,073 pic.twitter.com/odlhbhasiD — ANI (@ANI) &7

6:10 PM IST 6250 new Covid-19, 5275 recoveries and 25 deaths reported in Kerala today. Number of active cases now at 64,834; so far 526,797 patients have recovered: State Government

LIVE UPDATES

Mumbai reports 1,063 new Covid-19 cases in 24 hours

Karnataka reports 1,522 new Covid-19 cases, 12 deaths

Puducherry reports 46 new Covid-19 cases, 41 discharges.

Maharashtra reports 5,965 new Covid-19 cases in 24 hours

In process to apply for emergency use authorisation of Covishield: Serum CEO

Serum Institute CEO Adar Poonawalla said that they are process of applying for emergency use authorization of Covishield in the next two weeks. PM is extremely knowledgable now on vaccines & vaccine production. We were amazed at what he already knew.


He futher said that there was very little to explain to him, except for going into detail on different variable vaccines & the challenges that they may face ahead. As of now, we don't have anything in writing with the govt of India on how many doses they will purchase but the indication is that it would be 300-400 million doses by July, 2021.


"We have built the largest pandemic level facility in Pune & our new campus in Mandri. That was also showcased to the PM with a tour around the facility & a lot of detailed discussions. Vaccine will be distributed initially in India, then we will look at the COVAX countries which are mainly in Africa. The UK & European markets are being taken care of by AstraZeneca & Oxford. Our priority is India & COVAX countries", said Poonawalla to ANI.

Adar Poonawalla, CEO, Serum Institute


ICMR approves CSIR's Covid testing method

The Indian Council for Medical Research (ICMR) has approved a simple and fast method for COVID-19 testing which can not only increase the number of RT-PCR tests but can also bring down costs, the Council for Scientific and Industrial Research (CSIR) said on Saturday. The method -- Dry Swab-Direct RT-PCR -- developed by CSIR's Centre for Cellular and Molecular Biology, Hyderabad, is a variation of the existing gold standard RT-PCR method and can easily scale up the testing by 2 to 3 fold with no new investment of resources. "After evaluating this method and finding an overall concordance of 96.9 per cent, ICMR has now issued an advisory for the use of CSIR-CCMB dry swab method, considering its lesser cost and quick turn-around time," the CSIR said.


The CCMB has been testing samples for coronavirus since April. Having worked closely with healthcare workers of Telangana, it identified some of the key issues that slow the testing process. In response to it, the researchers developed the Dry Swab RNA-extraction free testing method for COVID-19. The Dry Swab-Direct RT-PCR method involves collecting and transporting the nasal swab in dry state, as opposed to using the viral transport medium VTM, which makes the transportation and handling of the samples easy and less prone to spillage and spread of infection. Secondly, the step of RNA isolation from the sample is omitted and involves only simple processing of the sample followed by direct RT-PCR using the kit recommended by the ICMR.

Delhi reports 4,998 new Covid-19 cases, tally at 561,742

Chandigarh reports 89 new Covid-19 cases, tally at 17,246

Had good interaction at Serum Institute, they shared details on vaccine progress: Modi

Tamil Nadu reports 1,430 Covid cases in a single-day

6250 new Covid-19, 5275 recoveries and 25 deaths reported in Kerala

6250 new Covid-19, 5275 recoveries and 25 deaths reported in Kerala today. Number of active cases now at 64,834; so far 526,797 patients have recovered: State Government

Over 50% Covid-19 beds unoccupied in Delhi: Satyender Jain

Health Minister Satyendar Jain on Saturday said more than 50 percent of the beds reserved for coronavirus patients in Delhi are unoccupied. More than 1,200 ICU beds and around 9,500 normal ones are unoccupied at present. Overall, more than 50 percent beds are available. So, we are in a slightly better situation, he told reporters. The minister said there were some problems related to oxygen supply in Delhi on Friday which have been resolved. Delhi reported 5,482 fresh COVID-19 cases on Friday, while 98 more fatalities pushed the city's death toll to 8,909.


The positivity rate was 8.51 percent. It was 8.65 percent on Thursday and 8.49 percent on Wednesday. On Friday, Jain had said Delhi has sufficient infrastructure and equipment to vaccinate its entire population in a few weeks once a COVID-19 vaccine was available. There is no need to worry about storage of vaccines. We have a large number of health care facilities, such as mohalla clinics, poly clinics, and hospitals etc., where COVID-19 vaccine can be administered to people, he had said.

Andhra Pradesh reports 625 new coronavirus cases

2,152 new coronavirus cases in Uttar Pradesh

2,152 new coronavirus cases in Uttar Pradesh, tally 540,000, active cases 25,243; toll 7,718 with 21 more deaths: health official

PM reviews Covid vaccine development at Serum Institute

PM at Serum Institute to review Covid-19 vaccine progress

Haryana to extend closure of schools for 10 more days amid Covid

State Health Minister Anil Vij said that schools in the state will remain closed for 10 more days in Haryana . The state government had earlier decided to keep the schools shut till November 30, in view of Covid-19 situation.

2,152 new Covid-19 cases take UP's tally to 539,899; death toll 7,718

The COVID-19 death toll in Uttar Pradesh rose to 7,718 on Saturday with 21 more fatalities, while 2,152 new cases pushed the infection tally to 5,39,899, a senior official here said. "The state has 25,243 active cases while 5,06,938 people have been treated and discharged. The death toll has risen to 7,718," Additional Chief Secretary (Health) Amit Mohan Prasad told reporters here.


The total number of cases on Saturday rose to 5,39,899 from 5,37,747 on Friday with 2,152 fresh cases, he said. Among the 25,243 active cases in the state, 12,293 are in home isolation, 2,253 are undergoing treatment in private hospitals and the rest are in government hospitals, where they are getting treatment free of cost, Prasad said. On Friday, over 1.74 lakh COVID-19 tests were conducted in the state, taking the total number of tests to over 1.89 crore, Prasad said.

Coronavirus LIVE: PM Modi arrives in Pune to visit Serum Institute to review vaccine development

Himachal CM decides to enforce 5-day office to break Covid-19 chain

Himachal Pradesh CM Jai Ram Thakur has said that the state govt has decided to enforce five days office and sixth days work from home for all govt employees of the state till December 15 to break COVID-19 chain. Himachal Pradesh has said that state government would also consider to impose curfew from 9 pm to 6 am in the four districts - Shimla, Mandi, Kullu and Kangra: CMO

PM's presence to motivate firm in quest to bridge unmet healthcare needs: Zydus Cadila

Drug firmZydus Cadila on Saturday said the presence of Prime Minister Narendra Modi at its Zydus Biotech Park will motivate the company to scale greater heights in its pursuit to bridge unmet healthcare needs. Modi visited Zydus Cadila's manufacturing facility near Ahmedabad, as he began his three-city visit to review ongoing coronavirus vaccine development work.


"His inspiring presence will motivate us to scale greater heights in our quest to bridge unmet healthcare needs,"Zydus Cadila said in a regulatory filing. The Zydus family comprising 25,000 Zydans stands committed to the 'Aatmanirbhar Bharat'mission and offering the nation safe and efficacious vaccines, therapeutics and diagnostics to fight COVID-19, it added. Zydus Cadila had earlier announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D is over and it commenced phase-II clinical trials from August.

 

PM Modi during his visit at Zydus Biotech Park

Uttarakhand CM takes stock of Covid situation, asks to increase tests across state

At a review meeting, Uttarakhand CM Trivendra Singh Rawat instructs officials of the health department to ensure the results of COVID-19 tests within 24 hours in urban areas and within 48 hours in hilly areas: Chief Minister's Office

Modi tweets on his visit to Biotech facility in Hyderabad, lauds scientists for vaccine progress

PM briefed on Covid vaccine of Bharat Biotech in Hyderabad

PM Narendra Modi was briefed about indigenous Covid-19 vaccine of Bharat Biotech at its facility in Hyderabad, Telangana today. "Congratulated scientists for their progress in the trials so far. Their team is closely working with ICMR to facilitate speedy progress," he tweets.

BJP to be blamed if Maharashtra faces second Covid-19 wave: minister

Maharashtra minister of state for Revenue Abdul Sattar has slammed the BJP for organising protests on streets amidst the COVID-19 pandemic. "The BJP will be responsible if the state is hit by a second wave of COVID-19 pandemic. The BJP is playing politics by gathering people (for protests)," Sattar told reporters in Nanded on Friday.


He ruled out the possibility of a lockdown in old format at this juncture. "The BJP is gathering people for protests and morchas. If this continues and if Maharashtra faces a second wave of coronavirus pandemic, the BJP will be responsible," he said. In a recent meeting with Prime Minister Narendra Modi, Chief Minister Uddhav Thackeray had raised the issue of "some parties" holding protests in the time of the COVID-19 pandemic, without naming the BJP.

Modi visits Bharat Biotech facility to review Covid-19 vaccine development

PM reaches Hyderabad to visit Bharat Biotech plant

Prime Minister Narendra Modi arrived here on Saturday as part of his three-city tour to take the stock of COVID-19 vaccine development. After landing at Hakimpet Air Force station here, he was received by Telangana Chief Secretary Somesh Kumar, Director General of Police and other officials. He will be proceeding to Bharat Biotech's facility located at Genome valley, a life sciences cluster about 20 km from the AF base, officials said.


Covid-19 vaccine, Covaxin, being developed by Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virologyis now undergoing phase-3 trials.


The vaccine is being developed and will be manufactured at Bharat Biotech's BSL-3 (Bio-Safety Level 3) facility in Genome Valley in Hyderabad. Modi will be interacting with scientists and senior management of the city-based vaccine maker onthe status of Covaxin, officials said. The PM will be flying back to the national capital after a stopover inPune, where he will visit the Serum Institute of India (SII), which has partnered with pharma giant AstraZeneca and the Oxford University for the vaccine. Earlier in the morning, Modi visited Zydus Cadila's plant near Ahmedabad.

 

Coronavirus LIVE: Modi arrives in Hyderabad, to visit Bharat Biotech facility

Delhi Health Minister Satyendra Jain on Covid-19 vaccine

Whenever the vaccine is available in Delhi, within 3-4 weeks it will be administered all over the national capital with the help of our health facilities such as polyclinics: Delhi Health Minister Satyendra Jain

Maha CM, Guv not to accompany PM during his SII visit in Pune

Maharashtra Governor B S Koshyariand Chief Minister Uddhav Thackeray will not accompany Prime Minister Narendra Modi during his visit to the Pune-based Serum Institute of India (SII) on Saturday.
 
The Chief Minister's Office (CMO) said this in a statement. "The chief minister and the governor will not be in Pune as the Prime Minister's Office (PMO) has informed that their presence was not required since the prime Minister will be there for a brief visit," the statement said.
 
Modi began his three-city visit on Saturday to review coronavirus vaccine development work by going to pharma major Zydus Cadila's manufacturing facility near Ahmedabad in the morning.

PODCAST: Lab to clinic: The genesis of coronavirus vaccine conversation in India

At a time when Prime Minister Narendra Modi is visiting three vaccine manufacturing facilities raising the pitch on the subject, a podcast by Nivedita Mookerji tells us how a presentation by a former Trai chief to the PMO, led to a conversation about the coronavirus vaccine in the corridors of power. Listen to the podcast here

27 new COVID-19 cases in Arunachal Pradesh; tally rises to

Arunachal Pradesh's COVID-19 caseload rose to 16,231 as 27 more people tested positive for the virus, a health department official said here on Saturday.

One more person succumbed to the infection on Friday, pushing the number of fatalities in the northeastern state to 50, State Surveillance Officer (SSO) Dr Lobsang Jampa said.

The 38-year-old woman died due to acute respiratory distress syndrome at the Dedicated Covid Hospital (DCH) at Chimpu near here, on Friday.

Of the 27 fresh cases, 10 were reported from the Capital Complex region, Changlang (6) and West Kameng (4), he said.

All shops except those selling essential items will remain closed on sundays in Dehradun

Dehradun: All shops except those selling essential items will remain closed on sundays due to surge in Covid-19 cases  Restrictions have to be placed as COVID19 cases are increasing in the city: Dr Ashish K Srivastav, District Magistrate Uttarakhand

Prime Minister Narendra Modi visits Zydus Biotech Park in Ahmedabad

Prime Minister Narendra Modi arrives at Gujarat's Ahmedabad, to visit the Zydus Biotech Park

COVID-19 caseload in India climbs to over 93.5 lakh

India's COVID-19 tally of cases climbed to 93.51 lakh with 41,322 new infections being reported in a day, while 87,59,969 people have recovered so far pushing the national recovery rate to 93.68 per cent, according to the Union health ministry data updated on Saturday.

The total coronavirus cases increased to 93,51,109 and the death toll climbed to 1,36,200 with the virus claiming 485 more lives, the data updated at 8 am showed.

'60-70% of population needs to be immune to curb Covid-19 transmission'

Modeling studies have revealed that about 60 to 70 per cent of the global population needs to be immune to curb or halt Covid-19 transmission, a World Health Organization (WHO) official said.
 
Noting the WHO cannot give the exact number of "the proportion of the population that would need to be immunized... The answer to that can come from modeling studies", Xinhua news agency quoted Katherine O'Brien, director of WHO's Department of Immunization, Vaccines and Biologicals, as saying at a virtual briefing on Friday.

18 new COVID-19 cases in Mizoram; tally rises to 3,806

At least 18 people, including four security personnel, have tested positive for COVID-19 in the last 24 hours, taking the state's tally to 3,806, an official said on Saturday.

Ten cases were reported from Aizawl district and four cases each were reported from Serchhip and Lawngtlai districts, he said.

Three Border Security Force (BSF) jawans and an Assam Rifles jawan were among the newly infected people, the official said.

He said that five patients have developed symptoms of COVID-19 while the remaining 13 patients were asymptomatic.

PM Modi reaches Ahmedabad to review coronavirus vaccine development

Prime Minister Narendra Modi landed here on Saturday as part of his three-city visit to ireview coronavirus vaccine development work at facilities there, an official said.
 
From the airport, Modi proceeded to pharma major Zydus Cadila's plant near Ahmedabad to get information about its vaccine development, official said.
 
The plant is located in the Changodar industrial area, over 20 km from Ahmedabad. Modi will be at the plant for an hour, beginning 9.30 am, the official said.
 
Zydus Cadila has announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D was over and it has commenced phase-II clinical trials from August.

Coronavirus India update: Summary of MoHFW data (November 28)

Active cases: 454,940 (Net decline: 615)
Deaths: 136,200 (Net addition: 485)
Cured: 8,759,969 (Net addition: 41,452)
Total cases: 9,351,110 (Net addition: 41,322)

1,074 new coronavirus cases in Mumbai, 17 deaths

Mumbai reported more than 1,000 new Covid-19 cases on the third day in a row on Friday, the Brihanmumbai Municipal Corporation's (BMC) said.
 
The city reported 1,074 new cases during the day, taking the tally to 2,80,811, while the death toll rose to 10,756 with 17 fresh fatalities, the BMC said.
 
The city had recorded 1,144 new cases on November 25 and 1,147 cases on November 26.

WHO warns countries with falling Covid-19 cases to stay 'vigilant'

Countries with decreasing Covid-19 numbers still need to stay "vigilant", a top World Health Organization (WHO) official said.
 
"Even as case numbers are coming down, all countries need to remain vigilant. You've heard of this before, but we really need to emphasize it again. Do not let your guard down," Xinhua news agency quoted Maria Van Kerkhove, technical lead for WHO's Health Emergencies Program, as saying at a virtual briefing on Friday.
 
"It's good to see the measures taking effect and transmission going down. But it's not time to let up. It's time to even scale up.
 
"What we don't want to see is situations where you are moving from a so-called lockdown state to bring the virus under control to moving to a so-called lockdown state," Van Kerkhove added.

Black Friday: Shoppers in US turn up in small numbers amid Covid fears

Masked shoppers turned up in smaller numbers at major U.S. retailers including Macy's Inc, Walmart Inc and Best Buy Co Inc on Black Friday as early online deals and worry about the spike in COVID-19 cases dulled enthusiasm for trips to the mall.
 
Retailers overhauled the traditionally busy shopping day that comes the day after Thanksgiving. Walmart opened stores at 5 a.m. on Friday, directing shoppers to turn right upon entering and proceed along main aisles to shop deals before paying at registers surrounded by plastic barriers. Read on...

1,607 new coronavirus cases in Gujarat; highest one-day spike

Despite night curfews in major cities and restrictions on gatherings in other parts of the state, Gujarat recorded its highest single-day spike of 1,607 coronavirus cases in 24 hours since Thursday evening.
 
The increase in new cases has crossed the 1,600-mark for the first time in the state.
 
The caseload, thus, reached 2,05,116, a health department release said on Friday.
 
The death toll due to coronavirus rose to 3,938 with 16 more infected patients dying.

Visit of foreign envoys to review coronavirus vaccine development at Pune's Serum Institute cancelled

The scheduled programme of foreign envoys who were expected to review the development of COVID-19 vaccines in Pune's Serum Institute got cancelled, according to Pune's district administration on Friday.
 
According to the administration, "The scheduled programme of foreign envoys to Pune on December 4 has been cancelled. About 100 envoys of different countries were scheduled to visit Pune's Serum Institute and Genova Biopharmaceuticals Limited on December 4 to review the development of COVID-19 vaccines."

Nepal's number of coronavirus cases reaches 229,343

Nepal reported 1,703 new Covid-19 cases in the past 24 hours, taking the national tally to 229,343, the health ministry said.
 
The new 1,703 cases were detected while conducting 10,460 PCR tests at various laboratories across the country.

World coronavirus update: UK records another 16,022 coronavirus cases with 521 deaths

Another 16,022 people in Britain have tested positive for Covid-19, bringing the total number of coronavirus cases in the country to 15,89,301, according to official figures released Friday.
 
The coronavirus-related deaths in Britain rose by 521 to 57,551, the data showed.
 
The figures came as the British government's Scientific Advisory Group for Emergencies (SAGE) warned that the relaxation of coronavirus restrictions over Christmas will increase infections by "potentially a large amount," the Xinhua news agency reported.
 
"Substantial mixing of people over a short period of time, especially those who do not make contact regularly during a month represents a significant risk for wide-spread transmission," SAGE said in "notes on festive period," a document published Friday.
 
"The prevalence could easily double during a few days of festive season," it added.

Data management has become top priority due to Covid: SAP's Kulmeet Bawa

In an interview with Business Standard, Kulmeet Bawa, MD and president for the Indian subcontinent at SAP, says how the German software maker is coping with the new normal. Click here to read more

Bihar coronavirus update: Tally rises to 233,839; death toll mounts to 1,248

Coronavirus tally climbs to 233,839 in Bihar after detection of 698 new cases in past 24 hours, five fresh fatalities raise death toll to 1,248; active case count 5,545: Health dept bulletin

PM Modi's Serum visit shot in arm for India's Covid-19 vaccine image

Located in Hadapsar, the peri-urban locality that connects Pune to the erstwhile textile-mill town of Solapur, Serum Institute of India (SII) appears ready to play a global role in the production of Covid-19 vaccine because few manufacturers can match the scale of its facilities.
 
Known for cranking out low-price vaccines that protect against polio, tetanus, and measles — often for less than $1 a dose — SII comes riding on the promise of a billion Covid shots. Read on...

Serum to submit data on two full doses of Covid-19 vaccine within deadline

Serum Institute of India (SII) will submit data from the two full doses’ clinical trials in the country to the Indian regulator within the planned timeline.
Sources said the UK partner, AstraZeneca, would also submit the current data set to the regulator as planned, and provide additional test results, if sought. If the Indian regulator seeks additional data on a wider population for the primer-booster dose regimen, then it can delay timelines. Read on...

PM Narendra Modi to visit Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad & Serum Institute of India in Pune today

PM Narendra Modi to visit Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad & Serum Institute of India in Pune today to personally review the Covid-19 vaccine development and manufacturing process.

Coronavirus in USA: The restaurant business is being absolutely decimated, says Donald Trump


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel